The pan-European STOXX 600 ended barely changed at 370.62, while markets in Frankfurt and Paris were flat and down 0.1 per cent, respectively. — Reuters pic
Pandemic uncertainties were compounded by news on Tuesday of halts to separate trials for a Covid-19 vaccine and a treatment, tempering a brief stock boost from US investment bank Goldman Sachs Group’s strong earnings report. “The fear is we are headed back towards a lockdown, not a re-opening of economies,” said Tim Ghriskey, chief investment strategist at Inverness Counsel in New York.
The pan-European STOXX 600 ended barely changed at 370.62, while markets in Frankfurt and Paris were flat and down 0.1 per cent, respectively. London, buffeted in part by Brexit angst, dropped 0.6 per cent. World stocks slipped 0.3 per cent but stayed within sight of the all-time high struck on September 3.